Tema Oncology ETFCANCETF
13F holders, Q2 2025 (June 30)5holders −1
1new positions
2sold out
$24.72avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Tema Oncology ETF (CANC) in their 13F filings, down 1 from Q1 2025. 1 opened new positions and 2 sold out. The largest holders were Thrivent Financial for Lutherans ($23.7M), Jane Street Group, LLC ($349K) and Raymond James Financial Inc. ($22K).
- Company
- Tema Oncology ETF
- Filed as
- TEMA ETF TRUST (Q2 2025)
- CUSIP
- 87975E701
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $22K |
| Exits | 2 | $13K |
All 13F filers, Q1 2025 → Q2 2025: 837,431 shares bought and 539 shares sold, net +836,892 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Thrivent Financial for Lutherans | 0.05% | Add +658.7% | 957,475 | $23.7M |
| Jane Street Group, LLC | 0.00% | Add +59.8% | 14,104 | $349K |
| Raymond James Financial Inc. | 0.00% | New | 875 | $22K |
| Osaic Holdings, Inc. | 0.00% | No change | 370 | $9K |
| Principal Securities, Inc. | 0.00% | No change | 50 | $1K |
"% of holder's portfolio" is CANC's weight in each manager's 13F, not the share of Tema Oncology ETF the manager owns.